The Journal of Immunology, Vol 155, Issue 6 3262-3267, Copyright © 1995 by American Association of Immunologists

ARTICLES

Perinuclear anti-neutrophil cytoplasmic antibodies are spontaneously produced by mucosal B cells of ulcerative colitis patients

SR Targan, CJ Landers, L Cobb, RP MacDermott and A Vidrich
Cedars-Sinai Inflammatory Bowel Disease Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Approximately 60% of sera from ulcerative colitis (UC) patients contains Igs reactive with neutrophil components, raising the question of the origin of these anti-neutrophil cytoplasmic Abs (ANCA). Our assertion that ANCA is a marker for a mucosal disease-related immune response predicts the existence of ANCA producing B cell clones in the lamina propria lymphocyte (LPL) fraction of UC patients. This hypothesis was tested by examining 12-day culture supernatants of LPL ANCA expression. LPL were isolated from surgically removed mucosa from patients with UC, Crohn's disease (CD), and diverticulitis. Normal mucosa was obtained from accident victims or normal margins of colon cancer resections. Supernatants were assayed by a fixed neutrophil ELISA. The ANCA staining pattern of supernatants expressing ANCA, as determined by ELISA, was assessed by indirect immunofluorescent staining of alcohol-fixed neutrophils. ANCA was found in 70% of culture supernatants from UC LPL fractions. In contrast, only approximately 11% of supernatants from CD and diverticulitis/normal (noninflammatory bowel disease (IBD)) LPL displayed ANCA binding. A perinuclear (pANCA) staining pattern was obtained with 70% of ANCA-expressing UC LPL supernatants, whereas ANCA-expressing CD and non-IBD LPL supernatants displayed a cytoplasmic reaction. PBL and mesenteric lymph node lymphocytes lacked spontaneous pANCA production, and pANCA production from PBL was not inducible. These findings indicate the existence of pANCA-producing B cell clones in mucosal lesions of UC patients and support our hypothesis that pANCA production is a consequence of a mucosal immune response specific to UC.

This article has been cited by other articles:

				V C Thoree, S J C Golby, L Boursier, M Hackett, D K Dunn-Walters, J D Sanderson, and J Spencer Related IgA1 and IgG producing cells in blood and diseased mucosa in ulcerative colitis Gut, July 1, 2002; 51(1): 44 - 50. [Abstract] [Full Text] [PDF]

				E A Vasiliauskas, L Y Kam, L C Karp, J Gaiennie, H Yang, and S R Targan Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics Gut, October 1, 2000; 47(4): 487 - 496. [Abstract] [Full Text] [PDF]

				M M-W Yeung, S Melgar, V Baranov, A Oberg, A Danielsson, S Hammarstrom, and M-L Hammarstrom Characterisation of mucosal lymphoid aggregates in ulcerative colitis: immune cell phenotype and TcR-gamma delta expression Gut, August 1, 2000; 47(2): 215 - 227. [Abstract] [Full Text] [PDF]

				L. Caradonna, L. Amati, T. Magrone, N.M. Pellegrino, E. Jirillo, and D. Caccavo Invited review: Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance Innate Immunity, June 1, 2000; 6(3): 205 - 214. [Abstract] [PDF]

				A. Mizoguchi, E. Mizoguchi, R. N. Smith, F. I. Preffer, and A. K. Bhan Suppressive Role of B Cells in Chronic Colitis of  T Cell Receptor alpha  Mutant Mice J. Exp. Med., November 17, 1997; 186(10): 1749 - 1756. [Abstract] [Full Text] [PDF]

				N P Breslin, A Todd, C Kilgallen, and C O'Morain Monozygotic twins with Crohn's disease and ulcerative colitis: a unique case report Gut, October 1, 1997; 41(4): 557 - 560. [Abstract] [Full Text] [PDF]